Trinity Biotech Recalls Captia Syphilis-G Test Kits Due to False Negatives
Trinity Biotech is recalling Captia Syphilis-G Test Kits because they may produce false negative results for syphilis antibodies.
What this means for you
Real risk of harm even if no illness or injury has been reported yet. Stop using the product and follow the agency's guidance.
Our severity reasoning: The recall involves a medical device that may produce false negative results for a serious infectious disease. This fits the 'High' severity criterion for risk-of-harm products where injury has not yet been reported.
Plain-English summary
Trinity Biotech, doing business as Clark Laboratories, Inc., is recalling 38 units of the Captia Syphilis-G Test Kit. The product is an enzyme immunoassay used to detect IgG antibodies to T. pallidum in serum specimens. The recall was initiated because the test kits may produce false negative results.
The affected products are identified by Product Code 800-960, Lot number 082, and Model 10 - plate kit. These kits were distributed nationwide in the United States, specifically within the state of Washington.
Healthcare providers and laboratories should stop using the affected test kits immediately. Users should contact the recalling firm for instructions on how to return the product or obtain a replacement.
The recalled product
- Product
- Captia Syphilis-G Test Kit Product Usage: This is an enzyme immunoassay for the qualitative detection of IgG antibodies to T. pallidum in serum specimens, to be used in conjunction with non-treponemal testing to provide serological evidence of infection with T. pallidum ( the
- Hazard
- Affected units
- 38
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (3)
- Product Code: 800-960
- Lot number: 082
- Model: 10 - plate kit
Distribution
Related recalls
Same manufacturer · Clark Laboratories, Inc. (dba,Trinity Biotech USA)
See all →- ModerateClark Laboratories Recalls Genesys Analytical Columns Due to Missing 510(k) Clearance
FDA (Devices) · 2018-12-26
- ModerateClark Laboratories Recalls Genesys 1 Reagent for Lack of 510(k) Clearance
FDA (Devices) · 2018-12-26
- ModerateClark Laboratories Recalls Genesys 2 Reagent Due to Lack of 510(k) Clearance
FDA (Devices) · 2018-12-26
- ModerateClark Laboratories Recalls ultra2 Genesys Variants Analyzer for Lack of 510(k)
FDA (Devices) · 2018-12-26
- ModerateClark Laboratories Recalls Genesys Diluent Reagent for Lack of 510(k) Clearance
FDA (Devices) · 2018-12-26
Same hazard · false negative result
See all →- HighBioFire Respiratory Panel 2.1 Recalled for Increased False Negative Results
FDA (Devices) · 2026-08-19
- HighVITEK 2 AST-N447 Test Kit Potentially Returns False Resistant Results
FDA (Devices) · 2026-07-15
- HighLuminex VERIGENE Gram Negative Blood Culture Test Recalled
FDA (Devices) · 2025-06-11
- HighVERIGENE Clostridium difficile Nucleic Acid Test May Give False-Negative Results
FDA (Devices) · 2023-07-05
- HighMedical device test system recalled for decreased reactivity and false-negative results
FDA (Devices) · 2022-12-07